Abstract
Pretazettine (1), which shows antileukemic activity, was obtained by conversion of tazettine (2) to 3-epitazettadiol (3) [whose structure was confirmed by its cyclization to deoxypretazettine (4)], followed by manganese dioxide oxidation of 3. The transformation of 2 to 1 confirmed the stereochemistry of pretazettine (1).